High dose ESAs are associated with high iPTH levels in hemodialysis patients with end-stage kidney disease: a retrospective analysis

• Päätekijät: Lan eChen (Tekijä), Yi-sheng eLing (Tekijä), Chun-hua eLin (Tekijä), Jin-Xuan eHe (Tekijä), Tian-Jun eGuan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2015-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: Anemia and secondary hyperparathyroidism are the two most common complications associated with chronic kidney disease (CKD). Erythropoiesis-stimulating agents (ESAs) are widely used in the management of anemia in hemodialysis patients. A reverse correlation has been established between hy...